Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX) Chemotherapy in the Front-Line Treatment of Patients With Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Evaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction Treatment
- Status
- UNKNOWN
- Phase
- PHASE3
Recombinant Anti-tumor and Anti-virus Protein for Injection Plus Xeloda in Treatment of Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Xeloda Maintenance Versus BSC in Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Retrospective Evaluation of 5-FU Exposure Optimization in CRC Patients
- Status
- COMPLETED
- Phase
- N/A
Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Maintenance Chemotherapy for Metastatic Colorectal Carcinoma and Biological Marker
- Status
- UNKNOWN
- Phase
- NA
Phase I / II Study of Enadenotucirev by Sub-acute Fractionated IV Dosing in Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Identification of Predictive Biomarker of Regorafenib in Refractory Colorectal Cancer
- Status
- COMPLETED
- Phase
- NA
Maintenance Therapy With 5-FU/FA Plus Panitumumab vs. 5-FU/FA Alone After Prior Induction and Re-induction After Progress for 1st-line Treatment of Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of TLBZT Based Herbal Therapy Plus Chemotherapy for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)
- Status
- COMPLETED
- Phase
- PHASE1
Study to Determine the Efficacy of Regorafenib in Metastatic Colorectal Cancer Patients and to Discover Biomarkers
- Status
- UNKNOWN
- Phase
- PHASE2
Metformin and 5-fluorouracil for Refractory Colorectal Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Phase Ib/II Study of Efficacy and Safety of MEK162 and Panitumumab, in Adult mCRC Patients With Mutant or Wild-type RAS Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Dual Targeting of EGFR With Cetuximab and Afatinib to Treat Refractory wtKRAS Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2